EO 14256
Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports
Economy & TradeNational SecurityLaw Enforcement
Ad Space (leaderboard)
Summary
This executive order removes the duty-free exemption for low-value imports from China and Hong Kong (valued at $800 or less) that would conceal synthetic opioid precursors or related materials, effective May 2, 2025. It imposes specific tariff duties on such shipments, including those sent through international postal networks, and requires carriers to report shipment information to U.S. Customs and Border Protection.
Key Points
- 1Eliminates duty-free 'de minimis' treatment for low-value Chinese and Hong Kong imports under $800 that contain synthetic opioid-related materials
- 2Applies to both commercial shipments and international postal packages from China and Hong Kong, effective May 2, 2025 at 12:01 AM EDT
- 3Requires U.S. Customs and Border Protection to collect tariffs on covered goods through the Automated Commercial Environment system and authorizes CBP to require carriers to remit payments monthly
- 4Postal carriers must report total numbers and values of affected items to CBP; duties imposed replace other applicable tariffs to streamline processing
- 5Applies to products described in previous executive orders (14195 and 14228) related to the synthetic opioid supply chain
This summary is for informational purposes only. It may not capture all nuances of the executive order. Always refer to the official text for authoritative information.
Ad Space (rectangle)